InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Kung Winston, 首席财务官. Director active across 3 companies, notably PMV Pharmaceuticals, Inc.. Cumulatively, 14 reports have been published. Split: 0 buy · 1 sell. History available since 3 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kung Winston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
2,026 股Common Stock, par value $0.0001 per shareSEC:0001193125-26-267672:0
3,800 股0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234860:0
3,750 股0Common StockSEC:0001415889-25-017310:0
4,800 股0Common Stock, par value $0.0001 per shareSEC:0000950170-25-080313:0
5,566 股0Common Stock, par value $0.0001 per shareSEC:0000950170-24-099175:0
2,500 股0Common StockSEC:0001415889-24-018441:0
2,560 股0Common StockSEC:0001209191-23-005476:0
4,000 股@ US$3.220.017% mcap8.7% 占其流量Common StockSEC:0001209191-22-025171:0
2,725 股0Common StockSEC:0001209191-22-007754:0
5,000 股@ US$3.2218.6% 占其流量Common StockSEC:0001209191-21-052784:0
4,500 股@ US$3.2216.5% 占其流量Common StockSEC:0001209191-21-049724:0
4,500 股@ US$3.2216.5% 占其流量Common StockSEC:0001209191-21-046054:0
4,500 股@ US$3.2216.1% 占其流量Common StockSEC:0001209191-21-038798:0
4,500 股@ US$3.2216.2% 占其流量Common StockSEC:0001209191-21-030096:0
14 条申报中的 14 条
About Kung Winston
Winston Kung is CFO and COO at PMV Pharmaceuticals, Inc. He oversees the financial operations and growth strategy of the company. His expertise in finance and operational management is crucial for the organization's development.
